BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06242834-completion@plaintrial.com
DTSTAMP:20261027T194047Z
DTSTART;VALUE=DATE:20281124
SUMMARY:Pembrolizumab and Tazemetostat to Overcome Immune Tolerance Followi
 ng ASCT or CAR T-cell Therapy in Patients With Aggressive B-Cell Non-Hodgk
 in's Lymphoma — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06242834
URL:https://plaintrial.com/trial/NCT06242834
END:VEVENT
END:VCALENDAR